Page last updated: 2024-10-28

hydralazine and Pulmonary Arterial Remodeling

hydralazine has been researched along with Pulmonary Arterial Remodeling in 3 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yan, Y1
Wang, C1
Lu, Y1
Gong, H1
Wu, Z1
Ma, X1
Li, H1
Wang, B1
Zhang, X1
Tarhouni, K1
Freidja, ML1
Guihot, AL1
Vessieres, E1
Grimaud, L1
Toutain, B1
Lenfant, F1
Arnal, JF1
Loufrani, L1
Henrion, D1
Pires, PW1
Jackson, WF1
Dorrance, AM1

Other Studies

3 other studies available for hydralazine and Pulmonary Arterial Remodeling

ArticleYear
Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma.
    Journal of physiology and biochemistry, 2018, Volume: 74, Issue:1

    Topics: ACTH-Secreting Pituitary Adenoma; Aldosterone; Animals; Antihypertensive Agents; Aorta; Cell Prolife

2018
Role of estrogens and age in flow-mediated outward remodeling of rat mesenteric resistance arteries.
    American journal of physiology. Heart and circulatory physiology, 2014, Aug-15, Volume: 307, Issue:4

    Topics: Age Factors; Animals; Benzimidazoles; Biphenyl Compounds; Cyclic N-Oxides; Estrogens; Female; Hydral

2014
Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.
    American journal of physiology. Heart and circulatory physiology, 2015, Jul-01, Volume: 309, Issue:1

    Topics: Animals; Antihypertensive Agents; Arterioles; Calcium; Calcium Channel Blockers; Calcium Channels, L

2015